26èmes Journées franco-belges de Pharmacochimie
24/05/2012
08:30Accueil des participants
09:00Séance inaugurale
Session Chair:
Dr. Franck SUZENET
(UNIVERSITÉ D'ORLÉANS, Orléans, France)
09:30L01 - Novel 5-HT7 antagonists for the treatment of migraine
Dr Ali ATES
(UCB, Braine-l'Alleud, Belgium)
10:20OC01 - Synthese de molecules d'intérêt pharmaceutique. Contribution à la synthèse des bastadines
Ing Christelle DECAMPS
(UMONS, Mons, Belgium)
10:40Pause café et communications par affiches, session 1
Session Chair:
Prof. Bernard PIROTTE
(ULG, Liège, Belgium)
11:30L02 - Foldamers: Expanding the Chemical Space
Dr Ivan HUC
(IECB & CNRS - UNIVERSITÉ DE BORDEAUX, Bordeaux, France)
12:20OC02 - Design, synthesis and biological evaluation of pyrazole-based kinase inhibitors
Dr Patricia BUSCA
(UNIVERSITY PARIS DESCARTES, Paris, France)
12:40OC03 - Design, synthesis and pharmacological evaluation of EGFR/VEGFR tyrosine kinase dual inhibitors
Ms Séverine RAVEZ
(ICPAL UNIVERSITÉ LILLE 2, Lille, France)
13:00Déjeuner
Session Chair:
Prof. François DUFRASNE
(ULB, Bruxelles, Belgium)
14:30OC04 - Synthesis of new molecular tools for the orphan receptor GLIC, homologous protein of the nicotinic acetylcholine receptors
Dr Sandrine DELARUE-COCHIN
(UNIVERSITE PARIS SUD, CHATENAY-MALABRY, France)
14:50OC05 - New alpha-galactosylceramides with potent immunoregulatory activity : synthesis and biological evaluation
Dr Muriel PIPELIER
(UNIVERSITÉ DE NANTES, Nantes, France)
15:10OC06 - Study of N1-alkylation of indoles from the reaction of 2(or 3)-aminoindole-3-(or 2)carbonitriles with DMF-dialkylacetals
Prof. Thierry BESSON
(UNIVERSITY OF ROUEN, Rouen Cedex 1, France)
15:30Pause café et communications par affiches, session 2
Session Chair:
Prof. Sylvain RAULT
(UNIVERSITÉ DE CAEN, Caen Cedex, France)
16:20L03 - Promoting Immune Rejection of Tumors by Blocking Tryptophan Catabolism by IDO and TDO
Prof. Benoît VAN DEN EYNDE
(LUDWIG INSTITUTE FOR CANCER RESEARCH LTD, UCL, DE DUVE INSTITUTE, Bruxelles, Belgium)
17:20Remise du prix des Journées Franco-belges de pharmacochimie
17:30Communication orale du lauréat
17:50Clôture de la séance
19:30Banquet
25/05/2012
Session Chair:
Prof. Bernard MASEREEL
(UNAMUR, Namur, Belgium)
09:00L04 - Development of cyclin dependent kinase inhibitors. Investigation of their molecular mechanism of action
Prof. Hervé GALONS
(SCT & PARIS DESCARTES UNIVERSITY, Paris, France)
09:50OC07 - Conception, synthese et evaluation de composes ciblant les ADN methyltransferases
Mr Irving BOITTIAUX
(FUNDP-UCL, Woluwe Saint Lambert, Belgium)
10:10OC08 - Activite antibacterienne, antioxyante et toxicite aiguë de quelques flavonoïdes
Dr Souâd AKROUM
(UNIVERSITY OF JIJEL, Jijel, Algerie)
10:30Pause café et communication par affiche, session 3
Session Chair:
Prof. Raphaël FREDERICK
(FUNDP, Bruxelles-Woluwé, Belgium)
11:00L05 - 3D pharmacophores in computational drug design: tools for hit discovery and lead optimization
Prof. Gerhard WOLBER
(FREIE UNIVERSITÄT BERLIN, Berlin, Germany)
11:50OC09 - Identification by a SOSA library screening and structure-activity relationships of succinic acid receptor (SUCNR1 or GPR91) agonist
Mrs Julie GILISSEN
(ULG, Liege, Belgium)
12:10OC10 - From the conception of FAAH inhibitors to the discovery of a novel class of selective CB2 cannabinoid receptor agonists in the treatment of experimental colitis
Ing Aurelien TOURTEAU
(UNIVERSITE DE LILLE 2, Lille, France)
12:30OC11 - Rational design of myeloperoxidase inhibitors using structure-based virtual screening
Mr Iyas ALDIB
(ULB, Brussels , Belgium)
12:50Déjeuner
Session Chair:
Prof. Patrick DEPREUX
(UNIVERSITÉ LILLE 2, Lille, France)
14:30OC12 - In vitro characterisation of anticancer properties relating to ferrocenyl and ferrocenophane complexes
Dr Céline BRUYÈRE
(ECOLE NATIONALE SUPÉRIEURE DE CHIMIE PARIS, Paris, France)
14:50OC13 - Assessing the free brain/free plasma ratio in vitro in early drug discovery
Mr Maxime CULOT
(BBB LAB (LBHE) - UNIVERSITY OF ARTOIS, Lens, France)
15:10L06 - Métabolomique et Chimie Médicinale, vers la découverte de nouvelles cibles thérapeutiques potentielles : application à la Dégénérescence Maculaire Liée à l’Age (DMLA)
Dr Pascal DE TULLIO
(ULG, Liege, Belgium)
16:00Remise des prix des meilleures communications par affiche
16:25Clôture du congrès
<Previous page


With the support of

Sponsored by

Exhibitors